(Q46965917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

A case-control study of non-alcoholic fatty liver disease in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

8 January 2020

main subject

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Ahmet Bilici

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Mustafa Ozguroglu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ismail Mihmanli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Hande Turna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

367-371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12032-007-0034-8

8 January 2020

exact match

0 references

cites work

Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-007-0034-8

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-007-0034-8

Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II, and E mRNA in rat liver and intestine

21 January 2018

1 reference

12 December 2020

Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction

1 reference

12 December 2020

The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E

1 reference

12 December 2020

Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.

1 reference

12 December 2020

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

12 December 2020

Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer

1 reference

12 December 2020

Paradoxical lack of ultrasound attenuation with gross fatty change in the liver

1 reference

12 December 2020

Elevated plasma tamoxifen levels in a patient with liver obstruction

1 reference

12 December 2020

Nonalcoholic steatohepatitis

1 reference

12 December 2020

Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist

1 reference

12 December 2020

Tamoxifen and liver damage

1 reference

12 December 2020

Tamoxifen-induced fatty liver in patients with breast cancer

1 reference

12 December 2020

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

12 December 2020

Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment

1 reference

12 December 2020

5-Fluorouracil/levamisole induced intrahepatic fat infiltration imitating liver metastasis

1 reference

12 December 2020

Nonalcoholic steatohepatitis in obesity: a reversible condition

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

12 December 2020

Nonalcoholic steatohepatitis: definition and pathology

1 reference

12 December 2020

Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis

1 reference

12 December 2020

Liver pathology and the metabolic syndrome X in severe obesity.

1 reference

12 December 2020

Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance

1 reference

12 December 2020

Nonalcoholic steatohepatitis

1 reference

12 December 2020

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

1 reference

12 December 2020

Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis

1 reference

12 December 2020

Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation

1 reference

12 December 2020

Tamoxifen-associated steatohepatitis--report of three cases

1 reference

12 December 2020

Liver morphology in morbid obesity: a literature study

1 reference

12 December 2020

Tamoxifen-induced transient multifocal hepatic fatty infiltration

1 reference

12 December 2020

Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen

1 reference

12 December 2020

Tamoxifen-induced steatohepatitis

1 reference

12 December 2020

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

12 December 2020

Noninvasive in vivo quantitative assessment of fat content in human liver

1 reference

12 December 2020

Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil

1 reference

12 December 2020

Cirrhosis with steatohepatitis after adjuvant tamoxifen

1 reference

12 December 2020

Tamoxifen therapy and hepatic steatosis.

1 reference

12 December 2020

10.1007/S12032-007-0034-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17917083%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference